Hormone-refractory (D3) prostate cancer: Refining the concept

This publication has 33 references indexed in Scilit:

• Case Reports: Withdrawal Phenomenon With the Antiandrogen Casodex
  Journal of Urology, 1995
• Surprising Activity of Flutamide Withdrawal, When Combined With Aminoglutethimide, in Treatment of "Hormone-Refractory" Prostate Cancer
  JNCI Journal of the National Cancer Institute, 1994
• Suramin, an Active Drug for Prostate Cancer: Interim Observations in a Phase I Trial
  JNCI Journal of the National Cancer Institute, 1993
• Suramin and prostate cancer: The role of hydrocortisone
  European Journal Of Cancer, 1992
• A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate
  Cancer, 1990
• Treatment of Stage D2 Prostatic Cancer Refractory to or Relapsed following Castration plus Oestrogens
  British Journal of Urology, 1990
• Suramin for prostatic cancer: A phase I/II study in advanced extensively pretreated disease
  European Journal of Cancer and Clinical Oncology, 1990
• A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
  New England Journal of Medicine, 1989
• Anti‐hormone Treatment for Prostate Cancer Relapsing after Treatment with Flutamide and Castration
  British Journal of Urology, 1989
• Treatment of advanced prostatic cancer, resistant to conventional therapy with aminoglutethimide
  European Journal of Cancer and Clinical Oncology, 1985